“Glucagon-Like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?”. 2026. Canadian Diabetes & Endocrinology Today 4 (1): 5–9. https://doi.org/10.58931/cdet.2026.4149.